Baxter Acquires Cobe Century Heart Lung Machine Via FTC Consent Decree
This article was originally published in The Gray Sheet
Executive Summary
Sorin Biomedica divested the Cobe Century heart lung machine business to Baxter on May 17 as part of a Federal Trade Commission consent decree in conjunction with Sorin's same-day acquisition of Cobe CardioVascular.